Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 2, 2016
Pharmacological treatment options for mast cell activation diseaseGerhard J Molderings, Britta Haenisch, Stefan Brettner, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 4, 2008
Regulatory mechanisms underlying agmatine homeostasis in humansBritta Haenisch, Ivar von Kügelgen, Heinz Bönisch, et al.
BMC Research Notes|May 22, 2024
Sex-specific cortical, hippocampal and thalamic whole genome transcriptome data from controls and a G72 schizophrenia mouse modelAnna Papazoglou, Christina Henseler, Sandra Weickhardt, et al.
Brain, Behavior, and Immunity|July 12, 2015
Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseasesLawrence B Afrin, Dieter Pöhlau, Martin Raithel, et al.
Plos One|September 20, 2018
Perspective of elderly patients on chronic use of potentially inappropriate medication - Results of the qualitative CIM-TRIAD studyKathrin Heser, Nadine Janis Pohontsch, Martin Scherer, et al.
The Pharmacogenomics Journal|February 1, 2022
Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenesJochen Fracowiak, Tatjana Huebner, Steffen Heß, et al.
Data in Brief|September 28, 2023
Whole genome transcriptome data from the WT cortex and hippocampus of female and male control and APP/PS1 Alzheimer's disease miceAnna Papazoglou, Christina Henseler, Sandra Weickhardt, et al.
Pageof 7